ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiac AI-assisted Diagnosis Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28O17024
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Cardiac AI assisted Diagnosis Software Market Research Report 2024
BUY CHAPTERS

Global Cardiac AI-assisted Diagnosis Software Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28O17024
Report
November 2025
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lepu Medical
G K Healthcare
Sense Time
United-imaging
Infervision
Shukun
Fosun Aitrox
NANO-X
MyCardium AI
VUNO
Caption Care
UltraSight
Ultromics
Cleerly
Elucid
DiA Imaging Analysis
Koninklijke Philips N V
Fujifilm

Cardiac AI-assisted Diagnosis Software Market

The global Cardiac AI-assisted Diagnosis Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cardiac AI-assisted Diagnosis Software leading manufacturers including Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X, MyCardium AI, VUNO, etc., dominate supply; the top five capture approximately % of global revenue, with Lepu Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cardiac AI-assisted Diagnosis Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Cardiac AI-assisted Diagnosis Software Market Report

Report Metric Details
Report Name Cardiac AI-assisted Diagnosis Software Market
Segment by Type
  • Cloud-based
  • On-Primes
Segment by Application
  • Hospital
  • Clinic
  • Imaging Center
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X, MyCardium AI, VUNO, Caption Care, UltraSight, Ultromics, Cleerly, Elucid, DiA Imaging Analysis, Koninklijke Philips N.V, Fujifilm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Cardiac AI-assisted Diagnosis Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Cardiac AI-assisted Diagnosis Software Market report?

Ans: The main players in the Cardiac AI-assisted Diagnosis Software Market are Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X, MyCardium AI, VUNO, Caption Care, UltraSight, Ultromics, Cleerly, Elucid, DiA Imaging Analysis, Koninklijke Philips N.V, Fujifilm

What are the Application segmentation covered in the Cardiac AI-assisted Diagnosis Software Market report?

Ans: The Applications covered in the Cardiac AI-assisted Diagnosis Software Market report are Hospital, Clinic, Imaging Center

What are the Type segmentation covered in the Cardiac AI-assisted Diagnosis Software Market report?

Ans: The Types covered in the Cardiac AI-assisted Diagnosis Software Market report are Cloud-based, On-Primes

1 Study Coverage
1.1 Introduction to Cardiac AI-assisted Diagnosis Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cardiac AI-assisted Diagnosis Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cloud-based
1.2.3 On-Primes
1.3 Market Segmentation by Application
1.3.1 Global Cardiac AI-assisted Diagnosis Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Imaging Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cardiac AI-assisted Diagnosis Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Cardiac AI-assisted Diagnosis Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Cardiac AI-assisted Diagnosis Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Cardiac AI-assisted Diagnosis Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cloud-based Market Size by Players
3.3.2 On-Primes Market Size by Players
3.4 Global Cardiac AI-assisted Diagnosis Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cardiac AI-assisted Diagnosis Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cardiac AI-assisted Diagnosis Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Cardiac AI-assisted Diagnosis Software Market Size by Type (2020-2031)
6.4 North America Cardiac AI-assisted Diagnosis Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cardiac AI-assisted Diagnosis Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Cardiac AI-assisted Diagnosis Software Market Size by Type (2020-2031)
7.4 Europe Cardiac AI-assisted Diagnosis Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cardiac AI-assisted Diagnosis Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Cardiac AI-assisted Diagnosis Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Cardiac AI-assisted Diagnosis Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Cardiac AI-assisted Diagnosis Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Cardiac AI-assisted Diagnosis Software Market Size by Type (2020-2031)
9.4 Central and South America Cardiac AI-assisted Diagnosis Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cardiac AI-assisted Diagnosis Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Cardiac AI-assisted Diagnosis Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Cardiac AI-assisted Diagnosis Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cardiac AI-assisted Diagnosis Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Lepu Medical
11.1.1 Lepu Medical Corporation Information
11.1.2 Lepu Medical Business Overview
11.1.3 Lepu Medical Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.1.4 Lepu Medical Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.1.5 Lepu Medical Cardiac AI-assisted Diagnosis Software Revenue by Product in 2024
11.1.6 Lepu Medical Cardiac AI-assisted Diagnosis Software Revenue by Application in 2024
11.1.7 Lepu Medical Cardiac AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.1.8 Lepu Medical Cardiac AI-assisted Diagnosis Software SWOT Analysis
11.1.9 Lepu Medical Recent Developments
11.2 G K Healthcare
11.2.1 G K Healthcare Corporation Information
11.2.2 G K Healthcare Business Overview
11.2.3 G K Healthcare Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.2.4 G K Healthcare Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.2.5 G K Healthcare Cardiac AI-assisted Diagnosis Software Revenue by Product in 2024
11.2.6 G K Healthcare Cardiac AI-assisted Diagnosis Software Revenue by Application in 2024
11.2.7 G K Healthcare Cardiac AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.2.8 G K Healthcare Cardiac AI-assisted Diagnosis Software SWOT Analysis
11.2.9 G K Healthcare Recent Developments
11.3 Sense Time
11.3.1 Sense Time Corporation Information
11.3.2 Sense Time Business Overview
11.3.3 Sense Time Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.3.4 Sense Time Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.3.5 Sense Time Cardiac AI-assisted Diagnosis Software Revenue by Product in 2024
11.3.6 Sense Time Cardiac AI-assisted Diagnosis Software Revenue by Application in 2024
11.3.7 Sense Time Cardiac AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.3.8 Sense Time Cardiac AI-assisted Diagnosis Software SWOT Analysis
11.3.9 Sense Time Recent Developments
11.4 United Imaging
11.4.1 United Imaging Corporation Information
11.4.2 United Imaging Business Overview
11.4.3 United Imaging Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.4.4 United Imaging Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.4.5 United Imaging Cardiac AI-assisted Diagnosis Software Revenue by Product in 2024
11.4.6 United Imaging Cardiac AI-assisted Diagnosis Software Revenue by Application in 2024
11.4.7 United Imaging Cardiac AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.4.8 United Imaging Cardiac AI-assisted Diagnosis Software SWOT Analysis
11.4.9 United Imaging Recent Developments
11.5 Infervision
11.5.1 Infervision Corporation Information
11.5.2 Infervision Business Overview
11.5.3 Infervision Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.5.4 Infervision Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.5.5 Infervision Cardiac AI-assisted Diagnosis Software Revenue by Product in 2024
11.5.6 Infervision Cardiac AI-assisted Diagnosis Software Revenue by Application in 2024
11.5.7 Infervision Cardiac AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.5.8 Infervision Cardiac AI-assisted Diagnosis Software SWOT Analysis
11.5.9 Infervision Recent Developments
11.6 Shukun
11.6.1 Shukun Corporation Information
11.6.2 Shukun Business Overview
11.6.3 Shukun Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.6.4 Shukun Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.6.5 Shukun Recent Developments
11.7 FOSUN AITROX
11.7.1 FOSUN AITROX Corporation Information
11.7.2 FOSUN AITROX Business Overview
11.7.3 FOSUN AITROX Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.7.4 FOSUN AITROX Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.7.5 FOSUN AITROX Recent Developments
11.8 NANO-X
11.8.1 NANO-X Corporation Information
11.8.2 NANO-X Business Overview
11.8.3 NANO-X Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.8.4 NANO-X Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.8.5 NANO-X Recent Developments
11.9 MyCardium AI
11.9.1 MyCardium AI Corporation Information
11.9.2 MyCardium AI Business Overview
11.9.3 MyCardium AI Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.9.4 MyCardium AI Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.9.5 MyCardium AI Recent Developments
11.10 VUNO
11.10.1 VUNO Corporation Information
11.10.2 VUNO Business Overview
11.10.3 VUNO Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.10.4 VUNO Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Caption Care
11.11.1 Caption Care Corporation Information
11.11.2 Caption Care Business Overview
11.11.3 Caption Care Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.11.4 Caption Care Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.11.5 Caption Care Recent Developments
11.12 UltraSight
11.12.1 UltraSight Corporation Information
11.12.2 UltraSight Business Overview
11.12.3 UltraSight Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.12.4 UltraSight Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.12.5 UltraSight Recent Developments
11.13 Ultromics
11.13.1 Ultromics Corporation Information
11.13.2 Ultromics Business Overview
11.13.3 Ultromics Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.13.4 Ultromics Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.13.5 Ultromics Recent Developments
11.14 Cleerly
11.14.1 Cleerly Corporation Information
11.14.2 Cleerly Business Overview
11.14.3 Cleerly Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.14.4 Cleerly Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.14.5 Cleerly Recent Developments
11.15 Elucid
11.15.1 Elucid Corporation Information
11.15.2 Elucid Business Overview
11.15.3 Elucid Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.15.4 Elucid Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.15.5 Elucid Recent Developments
11.16 DiA Imaging Analysis
11.16.1 DiA Imaging Analysis Corporation Information
11.16.2 DiA Imaging Analysis Business Overview
11.16.3 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.16.4 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.16.5 DiA Imaging Analysis Recent Developments
11.17 Koninklijke Philips N.V
11.17.1 Koninklijke Philips N.V Corporation Information
11.17.2 Koninklijke Philips N.V Business Overview
11.17.3 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.17.4 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.17.5 Koninklijke Philips N.V Recent Developments
11.18 Fujifilm
11.18.1 Fujifilm Corporation Information
11.18.2 Fujifilm Business Overview
11.18.3 Fujifilm Cardiac AI-assisted Diagnosis Software Product Features and Attributes
11.18.4 Fujifilm Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.18.5 Fujifilm Recent Developments
12 Cardiac AI-assisted Diagnosis SoftwareIndustry Chain Analysis
12.1 Cardiac AI-assisted Diagnosis Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cardiac AI-assisted Diagnosis Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cardiac AI-assisted Diagnosis Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Lepu Medical
G K Healthcare
Sense Time
United-imaging
Infervision
Shukun
Fosun Aitrox
NANO-X
MyCardium AI
VUNO
Caption Care
UltraSight
Ultromics
Cleerly
Elucid
DiA Imaging Analysis
Koninklijke Philips N V
Fujifilm
List of Tables
 Table 1. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Cardiac AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Cardiac AI-assisted Diagnosis Software Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Cardiac AI-assisted Diagnosis Software Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Cardiac AI-assisted Diagnosis Software Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Cardiac AI-assisted Diagnosis Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac AI-assisted Diagnosis Software as of 2024)
 Table 11. Global Cardiac AI-assisted Diagnosis Software Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Cardiac AI-assisted Diagnosis Software Companies Headquarters
 Table 13. Global Cardiac AI-assisted Diagnosis Software Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Cardiac AI-assisted Diagnosis Software Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Cardiac AI-assisted Diagnosis Software Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Cardiac AI-assisted Diagnosis Software Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Cardiac AI-assisted Diagnosis Software Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Cardiac AI-assisted Diagnosis Software High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Cardiac AI-assisted Diagnosis Software Growth Accelerators and Market Barriers
 Table 25. North America Cardiac AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Cardiac AI-assisted Diagnosis Software Growth Accelerators and Market Barriers
 Table 27. Europe Cardiac AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Cardiac AI-assisted Diagnosis Software Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Cardiac AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Cardiac AI-assisted Diagnosis Software Investment Opportunities and Key Challenges
 Table 31. Central and South America Cardiac AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Cardiac AI-assisted Diagnosis Software Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Cardiac AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Lepu Medical Corporation Information
 Table 35. Lepu Medical Description and Major Businesses
 Table 36. Lepu Medical Product Features and Attributes
 Table 37. Lepu Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Lepu Medical Revenue Proportion by Product in 2024
 Table 39. Lepu Medical Revenue Proportion by Application in 2024
 Table 40. Lepu Medical Revenue Proportion by Geographic Area in 2024
 Table 41. Lepu Medical Cardiac AI-assisted Diagnosis Software SWOT Analysis
 Table 42. Lepu Medical Recent Developments
 Table 43. G K Healthcare Corporation Information
 Table 44. G K Healthcare Description and Major Businesses
 Table 45. G K Healthcare Product Features and Attributes
 Table 46. G K Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. G K Healthcare Revenue Proportion by Product in 2024
 Table 48. G K Healthcare Revenue Proportion by Application in 2024
 Table 49. G K Healthcare Revenue Proportion by Geographic Area in 2024
 Table 50. G K Healthcare Cardiac AI-assisted Diagnosis Software SWOT Analysis
 Table 51. G K Healthcare Recent Developments
 Table 52. Sense Time Corporation Information
 Table 53. Sense Time Description and Major Businesses
 Table 54. Sense Time Product Features and Attributes
 Table 55. Sense Time Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Sense Time Revenue Proportion by Product in 2024
 Table 57. Sense Time Revenue Proportion by Application in 2024
 Table 58. Sense Time Revenue Proportion by Geographic Area in 2024
 Table 59. Sense Time Cardiac AI-assisted Diagnosis Software SWOT Analysis
 Table 60. Sense Time Recent Developments
 Table 61. United Imaging Corporation Information
 Table 62. United Imaging Description and Major Businesses
 Table 63. United Imaging Product Features and Attributes
 Table 64. United Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. United Imaging Revenue Proportion by Product in 2024
 Table 66. United Imaging Revenue Proportion by Application in 2024
 Table 67. United Imaging Revenue Proportion by Geographic Area in 2024
 Table 68. United Imaging Cardiac AI-assisted Diagnosis Software SWOT Analysis
 Table 69. United Imaging Recent Developments
 Table 70. Infervision Corporation Information
 Table 71. Infervision Description and Major Businesses
 Table 72. Infervision Product Features and Attributes
 Table 73. Infervision Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Infervision Revenue Proportion by Product in 2024
 Table 75. Infervision Revenue Proportion by Application in 2024
 Table 76. Infervision Revenue Proportion by Geographic Area in 2024
 Table 77. Infervision Cardiac AI-assisted Diagnosis Software SWOT Analysis
 Table 78. Infervision Recent Developments
 Table 79. Shukun Corporation Information
 Table 80. Shukun Description and Major Businesses
 Table 81. Shukun Product Features and Attributes
 Table 82. Shukun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Shukun Recent Developments
 Table 84. FOSUN AITROX Corporation Information
 Table 85. FOSUN AITROX Description and Major Businesses
 Table 86. FOSUN AITROX Product Features and Attributes
 Table 87. FOSUN AITROX Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. FOSUN AITROX Recent Developments
 Table 89. NANO-X Corporation Information
 Table 90. NANO-X Description and Major Businesses
 Table 91. NANO-X Product Features and Attributes
 Table 92. NANO-X Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. NANO-X Recent Developments
 Table 94. MyCardium AI Corporation Information
 Table 95. MyCardium AI Description and Major Businesses
 Table 96. MyCardium AI Product Features and Attributes
 Table 97. MyCardium AI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. MyCardium AI Recent Developments
 Table 99. VUNO Corporation Information
 Table 100. VUNO Description and Major Businesses
 Table 101. VUNO Product Features and Attributes
 Table 102. VUNO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. VUNO Recent Developments
 Table 104. Caption Care Corporation Information
 Table 105. Caption Care Description and Major Businesses
 Table 106. Caption Care Product Features and Attributes
 Table 107. Caption Care Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Caption Care Recent Developments
 Table 109. UltraSight Corporation Information
 Table 110. UltraSight Description and Major Businesses
 Table 111. UltraSight Product Features and Attributes
 Table 112. UltraSight Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. UltraSight Recent Developments
 Table 114. Ultromics Corporation Information
 Table 115. Ultromics Description and Major Businesses
 Table 116. Ultromics Product Features and Attributes
 Table 117. Ultromics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Ultromics Recent Developments
 Table 119. Cleerly Corporation Information
 Table 120. Cleerly Description and Major Businesses
 Table 121. Cleerly Product Features and Attributes
 Table 122. Cleerly Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Cleerly Recent Developments
 Table 124. Elucid Corporation Information
 Table 125. Elucid Description and Major Businesses
 Table 126. Elucid Product Features and Attributes
 Table 127. Elucid Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Elucid Recent Developments
 Table 129. DiA Imaging Analysis Corporation Information
 Table 130. DiA Imaging Analysis Description and Major Businesses
 Table 131. DiA Imaging Analysis Product Features and Attributes
 Table 132. DiA Imaging Analysis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. DiA Imaging Analysis Recent Developments
 Table 134. Koninklijke Philips N.V Corporation Information
 Table 135. Koninklijke Philips N.V Description and Major Businesses
 Table 136. Koninklijke Philips N.V Product Features and Attributes
 Table 137. Koninklijke Philips N.V Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Koninklijke Philips N.V Recent Developments
 Table 139. Fujifilm Corporation Information
 Table 140. Fujifilm Description and Major Businesses
 Table 141. Fujifilm Product Features and Attributes
 Table 142. Fujifilm Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Fujifilm Recent Developments
 Table 144. Raw Materials Key Suppliers
 Table 145. Distributors List
 Table 146. Market Trends and Market Evolution
 Table 147. Market Drivers and Opportunities
 Table 148. Market Challenges, Risks, and Restraints
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cardiac AI-assisted Diagnosis Software Product Picture
 Figure 2. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Cloud-based Product Picture
 Figure 4. On-Primes Product Picture
 Figure 5. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Imaging Center
 Figure 9. Cardiac AI-assisted Diagnosis Software Report Years Considered
 Figure 10. Global Cardiac AI-assisted Diagnosis Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Cardiac AI-assisted Diagnosis Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Region (2020-2031)
 Figure 14. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Cloud-based Revenue Market Share by Player in 2024
 Figure 17. On-Primes Revenue Market Share by Player in 2024
 Figure 18. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Type (2020-2031)
 Figure 19. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Application (2020-2031)
 Figure 20. North America Cardiac AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 22. North America Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Cardiac AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 29. Europe Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 32. France Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Cardiac AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 44. India Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Cardiac AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Cardiac AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 52. Central and South America Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Cardiac AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Cardiac AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Cardiac AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 58. South America Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Cardiac AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Cardiac AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Cardiac AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Cardiac AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Cardiac AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 64. Cardiac AI-assisted Diagnosis Software Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Cardiac AI assisted Diagnosis Market Research Report 2024
Global Cardiac AI assisted Diagnosis Solution Market Research Report 2024
Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Software Market Research Report 2024
Global Medical AI assisted Diagnosis Software Market Research Report 2024
Global Breast AI assisted Diagnosis Software Market Research Report 2024
Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Market Research Report 2024
Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Solution Market Research Report 2024
Global Brain AI assisted Diagnosis Software Market Research Report 2024
Global Lung AI assisted Diagnosis Software Market Research Report 2024
Global Medical AI assisted Diagnosis Product Market Research Report 2024
Global Bone AI assisted Diagnosis Software Market Research Report 2024
Global Medical AI assisted Diagnosis Market Research Report 2024
Global Ophthalmic AI assisted Diagnosis Software Market Research Report 2024
Global Medical AI assisted Diagnosis Solution Market Research Report 2024
Global Liver AI assisted Diagnosis Software Market Research Report 2024
Global AI Cardiovascular Screening System Market Research Report 2024
Global Breast AI assisted Diagnosis Market Research Report 2024
Global Breast AI assisted Diagnosis Solution Market Research Report 2024
Global AI Medical Diagnosis App Market Research Report 2024
Global AI Medical Diagnosis Tool Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions